Institutional Ownership
Theravance Biopharma Inc
CUSIP G8807B106COMTBPHQ1 2026
Institutional Holders
165
13F filers
Shares Held
47.30M
Aggregate institutional
Institutional Value
$737.97M
Q1 2026
Net New Holders
+0
34 new · 34 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions34
Increased61
Decreased45
Sold out34
Institutional Holders
165 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Madison Avenue Partners, LP | 9.51M | $154.37M | 0 | Held |
| 2 | Weiss Asset Management LP | 7.46M | $121.03M | +7.46M | New |
| 3 | Newtyn Management, LLC | 4.84M | $78.58M | +541.6K | Added |
| 4 | Blackrock, Inc. | 4.30M | $69.73M | +245.8K | Added |
| 5 | Irenic Capital Management LP | 2.76M | $44.81M | 0 | Held |
| 6 | State Street Corp | 1.30M | $21.06M | +195.4K | Added |
| 7 | Two Sigma Investments, LP | 1.26M | $20.43M | +721.2K | Added |
| 8 | Geode Capital Management, LLC | 1.14M | $18.46M | +198.7K | Added |
| 9 | Dimensional Fund Advisors LP | 983.6K | $15.96M | +124.7K | Added |
| 10 | D. E. Shaw & Co., Inc. | 954.0K | $15.48M | −305.9K | Reduced |
155 more institutional holders on Premium
See every fund holding Theravance Biopharma Inc, with full quarter-over-quarter share changes.
Unlock all holders